Search for: "PREFERRED PHARMACEUTICALS, INC" Results 61 - 80 of 431
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jan 2021, 1:48 pm by luiza
Bausch Health (formerly Valeant Pharmaceuticals) – In yet another case of accounting fraud, the SEC obtained a $45 million penalty from Bausch Health, formerly known as Valeant Pharmaceuticals, to resolve charges that its executives engaged in improper revenue recognition and misleading disclosures in SEC filings and earnings presentations. [read post]
4 Jan 2021, 2:02 pm by Cynthia Marcotte Stamer
  The indictment also alleges that, with the proceeds of the fraud, the defendants engaged in a complex money laundering conspiracy where they created sham pharmacy wholesale companies, which they named after pre-existing pharmacy wholesalers, and fabricated invoices to make it appear that funds transferred from the pharmacies to the sham pharmacy wholesale companies  were for legitimate pharmaceutical drug purchases. [read post]
4 Jan 2021, 1:26 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2020 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
10 Dec 2020, 3:50 am
"] In re Globus Medical, Inc., Serial No. 88676830 (December 8, 2020) [not precedential] (Opinion by Judge Christen M. [read post]
21 Nov 2020, 5:56 am by Renae Lloyd
  The problem with pharmaceutical and biotech investments is that they typically involve a high degree of risk. [read post]
1 Sep 2020, 7:35 am by Jason Rantanen
  For this reason, SEP holders strongly prefer to license their SEPs to end device makers (Tier 3). [read post]
3 Aug 2020, 7:02 am by Elizabeth McAuliffe (Bristows)
The parties’ experts, Professor Patrick Wheeler of Nottingham University for Lufthansa and Mr Douglas Hay Barovsky of Engineering Systems Inc. for the Defendants disagreed on many points, in particular the identity of the skilled person. [read post]
17 Jul 2020, 9:26 am by luiza
(FTC) Huu Tieu, 58, of Porterville, California, president and CEO of Golden Sunrise Pharmaceutical Inc. and Golden Sunrise Nutraceutical Inc., was arrested after a 5-count grand jury indictment was returned, charging him with mail fraud and introducing a misbranded drug into interstate commerce with the intent to defraud. [read post]
Similarly, a client in veterinary pharmaceuticals wanted to locate potential salespeople with three specific skill sets: the know-how, energy, and ability to connect with and sell to customers; the knowledge of complex pharmaceutical products; and the ability to “speak horse. [read post]
13 May 2020, 2:03 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592 n.10 (1993). [3]  Id., citing Bourjaily v. [read post]
24 Apr 2020, 6:58 am by Lisa Larrimore Ouellette
Both the Federal Circuit and the predecessor Court of Claims have deemed reasonable royalty awards to be “the preferred manner” of compensation under section 1498; in Tektronix Inc. v. [read post]
13 Apr 2020, 4:19 pm by Kevin LaCroix
After all, “[t]he empirical evidence on the [Private Securities Litigation Reform Act’s] lead plaintiff provision suggests that courts should continue their preference for institutional over individual plaintiffs in securities class actions,” says St. [read post]
2 Mar 2020, 11:04 am by Cynthia Marcotte Stamer
Today (March 2, 2020) is the deadline for employers and other health benefit program sponsors, insurers, plan administrators and fiduciaries, health care providers, PBMs and other interested persons to comment on proposed federal rule change that would require insured health plans to count drug rebates and price concessions retained by pharmacy benefit managers (PBMs) as administrative expenses for purposes of determining if the issuing insurer is required to rebate premiums under the medical loss… [read post]